Jerry Kronenberg

 Jerry Kronenberg is managing editor TheStreet and TST Premium Services.

 A veteran business journalist, Kronenberg has held senior editorships at CNN Financial News, United Press International and the Boston Herald. He is also a former vice president of Fidelity Investments.

Recent Articles By The Author

Broadcom's Stock Could Easily Skyrocket Almost 30% From Here

Broadcom's Stock Could Easily Skyrocket Almost 30% From Here

Chip giant could hit $350 if it manages to buy Qualcomm for $80 a share or less.

Jim Cramer Likes PepsiCo and First Data Corp. (But Not Kraft Heinz or AEP)

Jim Cramer Likes PepsiCo and First Data Corp. (But Not Kraft Heinz or AEP)

Two names look good for 2018, but two don't.

Don't Expect a Bruising U.S. Recession in 2018: Jim Cramer

Don't Expect a Bruising U.S. Recession in 2018: Jim Cramer

Too many CEOs are telling him that things look good.

U.S. Investor Confidence Is Growing, Jim Cramer and Other Experts Say

U.S. Investor Confidence Is Growing, Jim Cramer and Other Experts Say

Americans suddenly seem more enthusiastic.

What Under Armour's CEO Told Jim Cramer

What Under Armour's CEO Told Jim Cramer

'I lost focus' ... and UA's stock price slid.

3 Great Defense Stocks

3 Great Defense Stocks

Why our Trading Strategies panelists like Lockheed Martin, Northrop Grumman and Kratos Defense & Securities Solutions.

Great Stock Picks for November

Great Stock Picks for November

From Citigroup to Schlumberger, here's what our expert panel recommends.

Fed Nominee Powell 'Wants People to Be Wealthy,' Jim Cramer Says

Fed Nominee Powell 'Wants People to Be Wealthy,' Jim Cramer Says

President Trump's pick to replace Janet Yellen as Federal Reserve chief seems investor-friendly.

Jim Cramer Says DowDuPont Is 'Perhaps the Most Attractive Stock' My Trust Owns

Jim Cramer Says DowDuPont Is 'Perhaps the Most Attractive Stock' My Trust Owns

New CEO seems likely to unlock tons of value.

Allergan Is the Cheapest Big-Cap Drug Stock in the Universe: Jim Cramer

Allergan Is the Cheapest Big-Cap Drug Stock in the Universe: Jim Cramer

Cramer says he'll buy more shares of the lackluster drugmaker for his charitable trust if the price drops below $200.